Provenance du réseau au premier degré de Daina Vanags
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.
22
| Extinct | Biotechnology | 22 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Daina Vanags via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ANALYTICA | Medical Specialties | Director/Board Member Director/Board Member Chairman Director/Board Member Corporate Secretary Director of Finance/CFO Director/Board Member | |
| INVION LIMITED | Pharmaceuticals: Major | Chairman Chairman Director/Board Member Director/Board Member Director of Finance/CFO | |
| The University of Queensland | College/University | Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Australian Technology Innovation Fund Ltd.
 Australian Technology Innovation Fund Ltd. Financial ConglomeratesFinance Australian Technology Innovation Fund Ltd. is an investment company that is not classified elsewhere. | Financial Conglomerates | Chairman Director/Board Member Director/Board Member | |
Hospira Adelaide Pty Ltd.
 Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director of Finance/CFO | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Uppsala | College/University | Undergraduate Degree Graduate Degree | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| VIRALYTICS LTD. | Biotechnology | Director/Board Member Director/Board Member | |
| Tenement to Terminal Ltd. | Director/Board Member | ||
Citigroup Global Markets Australia Pty Ltd.
 Citigroup Global Markets Australia Pty Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Australia Pty Ltd. (Citi Australia) is the brokerage arm of Citigroup Global Markets Australia Holdings Pty Ltd., ultimately held by Citigroup, Inc., (NYSE: C) in the US. Headquartered in Sydney with additional office in Melbourne, Citi Australia provides brokerage services to Australian consumers, corporations, institutions and governments. The firm participate in sales and trading across all asset classes including equities, corporate, government and agency bonds, mortgage-backed securities, syndicated loans, structured products, foreign exchange and futures. | Investment Banks/Brokers | Analyst-Equity | |
| DIVERSA LIMITED | Investment Managers | Chairman | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Wilson HTM Charities Ltd. | Director/Board Member | ||
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
ClanoTech AB
 ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| The Board of Taxation | Corporate Officer/Principal | ||
| University of Lund | College/University | Corporate Officer/Principal | |
| Clime AFM Pty Ltd. | Founder | ||
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Australian Financial Management Investment Pty Ltd.
 Australian Financial Management Investment Pty Ltd. Investment ManagersFinance Part of Clime Investment Management Ltd., Australian Financial Management Investment Pty Ltd. is an independent wealth advisory firm. The company is based in Brisbane, Australia. The Australian company was founded by Warren Stephen Brooks. | Investment Managers | Founder | |
Meridian Minerals Pty Ltd.
 Meridian Minerals Pty Ltd. Precious MetalsNon-Energy Minerals Meridian Minerals Ltd. is an Australian based diverse mineral resource development and exploration company. Its principal activity includes exploration for base metals and gold. Meridian Minerals projects include Lennard Shelf Zinc Lead Project is located in the Kimberley region of Western Australia, Lachlan Fold Belt tenements in New South Wales and Thomson Fold Belt Project exploration region in northern New South Wales. The company was founded in 2007 and is headquartered in Milton, Australia | Precious Metals | Corporate Secretary | |
| SUNSTONE METALS LIMITED | Precious Metals | Corporate Secretary | |
Kirby-Smith Machinery, Inc.
 Kirby-Smith Machinery, Inc. Wholesale DistributorsDistribution Services Kirby-Smith Machinery, Inc. distributes of heavy construction equipment, industrial equipment and cranes. It serves the construction, paving, industrial, aggregate, pipeline/oilfield service, and various other industries. The company was founded by Hoyt Edgar Kirby Jr. in 1983 and is headquartered in Oklahoma City, OK. | Wholesale Distributors | Corporate Officer/Principal | |
| NEW GUINEA GOLD CORPORATION | Precious Metals | Director of Finance/CFO | |
| Southern Cross University | College/University | Undergraduate Degree | |
| BYTE POWER GROUP LIMITED | Information Technology Services | Director of Finance/CFO | |
| Arts Biologics A/S | Director/Board Member | ||
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| Godbar Software | Corporate Officer/Principal | ||
| EMPIRE OIL & GAS NL | Oil & Gas Production | Director/Board Member | |
Shell Energy Retail Pty Ltd.
 Shell Energy Retail Pty Ltd. Electric UtilitiesUtilities Part of Shell Plc, Shell Energy Retail Pty Ltd. is an Australian company that engages in the generation and sale of electricity and gas exploration. The company is based in Brisbane, Australia. William Mitchell Anderson has been the CEO of the company since 2007. | Electric Utilities | Director/Board Member | |
| APOLLO TOURISM & LEISURE | Recreational Products | Director/Board Member | |
Hamilton Locke
 Hamilton Locke Miscellaneous Commercial ServicesCommercial Services Hamilton Locke is a law firm based in Sydney, Australia. Hamilton Locke operates as a law firm. The Australian company was founded by Hal Lloyd, Nick Humphrey. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Jones Day LP
 Jones Day LP Miscellaneous Commercial ServicesCommercial Services Jones Day LP provides legal services. It offers services to the airlines, aviation, automotive, construction, energy, healthcare, insurance, media, pharmaceuticals, and telecommunication industries. The company was founded by Edwin J. Blandin and William Lowe Rice on March 1, 1893 and is headquartered in Cleveland, OH. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| TOURISM HOLDINGS LIMITED | Finance/Rental/Leasing | Director/Board Member | |
Unity Pacific Ltd.
 Unity Pacific Ltd. Real Estate DevelopmentFinance Part of Ebert Investments Pty Ltd., Unity Pacific Ltd. is an Australian company that provides real estate services. The company is based in Brisbane, Australia. | Real Estate Development | Chairman | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Unity Pacific Investment Management Ltd. | Chairman | ||
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Medical Specialties | Director/Board Member |
Statistiques
Internationale
| Australie | 32 |
| Suède | 11 |
| Etats-Unis | 6 |
| Danemark | 4 |
| Nouvelle-Zélande | 2 |
Sectorielle
| Health Technology | 18 |
| Consumer Services | 7 |
| Finance | 7 |
| Commercial Services | 6 |
| Non-Energy Minerals | 5 |
Opérationnelle
| Director/Board Member | 123 |
| Chairman | 51 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 31 |
| Corporate Secretary | 14 |
Relations les plus connectées
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Peter Corr | 28 |
| James Brett Lochran Heading | 24 |
| Ralph Craven | 23 |
| Terje Kalland | 20 |
| James Campbell | 18 |
| Steve P. Jones | 14 |
| Melanie Farris | 12 |
| Thomas Lönngren | 11 |
| Stephen Streeter | 11 |
| John Watson Funder | 8 |
| Michael Monsour | 7 |
| Roslynn Judith Shand | 6 |
| Jason Richard Yeates | 6 |
| Ben Graham | 5 |
- Bourse
- Insiders
- Daina Vanags
- Connexions Sociétés
